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Reply to 'Imatinib induces apoptosis in CLL lymphocytes with high expression of Par-4' by Chow et al Leukemia (2005) The interesting results reported by Dr Chow et al are complementary to our findings, bringing insights into the possible mechanism of STI571-induced apoptosis in primary CLL lymphocytes. 1, 2 The authors suggest the involvement of a new apoptotic pathway involving the caspase 3 activator, prostate apoptosis response gene 4 (Par-4). Moreover, Par-4 protein levels looks to correlate with the responsiveness to STI571 in a panel of six of CLL primary lymphocytes. 1 Interestingly, it has been proposed that caspase-3 induction is involved in chlorambucil (CLB)-induced CLL lymphocytes apoptosis. 3 In this regard, the fact that we did not find a correlation between the CLB and STI571 IC 50 when used alone suggests that the mechanisms downstream of STI571 and CLBinduced apoptosis are not identical. 1 Thus, it will be informative to assess the involvement of Par-4 protein levels in CLB-induced apoptosis in primary CLL lymphocytes. If STI571 induces Par-4 while CLB does not, the mechanism of action proposed by Dr Chow et al may explain the lack of correlation mentioned before and account in part for the synergistic affect of both drugs reported by our group. Nevertheless, the fact that we did not find a correlation between the CLB IC 50 in the presence of STI571 and the STI571 IC 50 is not in keeping with this hypothesis. Moreover, it has been shown that in CHO cells, proteolytic inactivation of Rad51 by a caspase-mediated mechanism contributes to the cell death response induced by IR-mediated DNA damage. 4 If this mechanism takes place in human B-lymphocytes, STI571 may decrease Rad51 related homologous recombinational repair (HRR) not only by decreasing c-abl-mediated Rad51 phosphorylation [5] [6] [7] and consequently HRR but also decreasing Rad51 protein levels. We summarize the possible pathways involved in STI571 and CLB-induced apoptosis in B-lymphocytes in Figure 1 . 
Figure 1
Shortly after CLB induced-DNA damage (early events), the nonreceptor tyrosine kinase, c-abl, is activated and phosphorylates a series of downstream targets including Rad51. Rad51 phosphorylation by c-abl increases Rad51 directed DNA repair. Eventually (later events), if DNA damage exceeds the DNA repair capacity of treated cell, programmed cell death is triggered. STI571 induces apoptosis in lymphoid cells by activation of the caspase-3 pathway. Thus, STI51 may affect the response to DNA damage of lymphoid cells at two levels: (a) affecting the DNA repair process itself (early events) by decreasing c-abl mediated Rad51 phosphorylation and/or (b) increasing caspse-3 activation.
